Death risk higher with conventional than with atypical antipsychotics

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1517, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Higher than Physician’s Desk Reference (US) doses on atypical antipsychotics

By Goodnick Paul J

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 653-668

Informa Healthcare

Access to resources Recommend Favorite

Conventional and Atypical Antipsychotics in the Elderly: A Review

By Gareri P.

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 287-322

Adis International

Access to resources Recommend Favorite

Stroke risk with typical and atypical antipsychotics

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study

By Broekema W. Groot I. Harten P.

Pharmacy World and Science, Vol. 29, Iss. 3, 2007-06 ,pp. : 126-130

Springer Publishing Company

Access to resources Recommend Favorite

The risk of tardive dyskinesia appears to be lower for olanzapine (2.5-20mg) than for conventional antipsychotics

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite